Hormonal contraceptive eligibility for women at high risk of HIV

Guidance Statement
World Health Organization, Department of Reproductive Health and Research, 2017

20 pp. 2.5 MB

The World Health Organization (WHO) convened a technical consultation during 1–2 December 2016 to review new evidence on the risk of HIV acquisition with the use of hormonal contraception. The issue was recognized as a critical one, particularly for sub-Saharan Africa, where women have a high lifetime risk of acquiring HIV, hormonal contraceptives constitute a significant component of the contraceptive method mix and unintended pregnancy is a common threat to the well-being and lives of women and girls. Through consensus, the Guideline Development Group (GDG) arrived at new recommendations for progestogen-only injectables and that women at high risk of acquiring HIV can use all methods of contraception.

(Visited 33 times, 1 visits today)
This entry was posted in General, HIV - AIDS - STI, Maternal & Child Health, Sexual & Reproductive Health. Bookmark the permalink.